Representation Analysis of miRNA in Urine Microvesicles and Cell-Free Urine in Prostate Diseases


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Somente assinantes

Resumo

Urine of prostate cancer patients contains tumor-specific biopolymers, including protein- and microvesicles-associated miRNAs that can potentially be used as oncomarkers. Previously we have characterized urinary extracellular vesicles and demonstrated diagnostic potential of their miRNAs. In this study, we have performed a comparative analysis of 84 miRNA in paired samples of urine microvesicles and urine supernatant from healthy men, patients with benign prostate hyperplasia, and prostate cancer patients using miRCURY LNA miRNA qPCR Panels. In all groups of patients, miRNA subsets characterized by different distribution between the urinary fractions have been found. In this context, two groups of miRNAs have been identified, which are involved in several signaling pathways including those associated with prostate cancer development.

Sobre autores

I. Zaporozhchenko

Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center

Autor responsável pela correspondência
Email: ivanzap@niboch.nsc.ru
Rússia, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk

O. Bryzgunova

Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center

Email: ivanzap@niboch.nsc.ru
Rússia, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk

E. Lekchnov

Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center

Email: ivanzap@niboch.nsc.ru
Rússia, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk

I. Osipov

Novosibirsk State University

Email: ivanzap@niboch.nsc.ru
Rússia, Novosibirsk

M. Zaripov

Siberian District Medical Center

Email: ivanzap@niboch.nsc.ru
Rússia, Novosibirsk

Yu. Yurchenko

Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences

Email: ivanzap@niboch.nsc.ru
Rússia, pr. Akad. Lavrentieva 8, Novosibirsk, 630090

S. Yarmoschuk

Meshalkin Siberian Federal Biomedical Research Center

Email: ivanzap@niboch.nsc.ru
Rússia, Novosibirsk

O. Pashkovskaya

Meshalkin Siberian Federal Biomedical Research Center

Email: ivanzap@niboch.nsc.ru
Rússia, Novosibirsk

E. Rykova

Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center

Email: ivanzap@niboch.nsc.ru
Rússia, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk

A. Zheravin

Meshalkin Siberian Federal Biomedical Research Center

Email: ivanzap@niboch.nsc.ru
Rússia, Novosibirsk

P. Laktionov

Institute of Chemical Biology and Fundamental Medicine of Siberian Branch of the Russian Academy of Sciences; Meshalkin Siberian Federal Biomedical Research Center

Email: ivanzap@niboch.nsc.ru
Rússia, pr. Akad. Lavrentieva 8, Novosibirsk, 630090; Novosibirsk

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML

Declaração de direitos autorais © Pleiades Publishing, Ltd., 2018